NCT02580110

Brief Summary

The study intention is to investigate, in healthy humans, effects of 3 commonly used sweeteners on cardiometabolic risk markers, cognitive functions, and influences on gut microbiota composition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

October 14, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 20, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

June 23, 2016

Status Verified

June 1, 2016

Enrollment Period

8 months

First QC Date

October 14, 2015

Last Update Submit

June 22, 2016

Conditions

Keywords

no specific condition

Outcome Measures

Primary Outcomes (6)

  • Incremental area under the curve (iAUC) (Glucose tolerance)

    The iAUC are determined after a standardized breakfast based on white wheat bread (50g available starch). The breakfast was commenced at time=0 and consumed within 10-12 min.

    predose (standardised breakfast), 0, 15, 30, 45, 60, 90, 120, 150, and 180 min post dose.

  • Incremental area under the curve (iAUC) (insulin sensitivity).

    The iAUC are determined after a standardized breakfast based on white wheat bread (50g available starch). The breakfast was commenced at time=0 and consumed within 10-12 min.

    predose, 0 (fasting), 15, 30, 45, 60, 90, 120, 150, and 180 min post-dose.

  • Working memory capacity

    Working memory capacity determined with an oral working memory test composed of short sentences that can be semantically meaningful or not. 3-5 sentences are read to the subject. After each sentence the subject immediately has to reply if the sentence is semantically meaningful or not. After the set of 3-5 sentences the subjects have to recall the first noun in each of the sentences. One test is composed of 12 set with (3-5) sentences.

    80 min after the standardised breakfast

  • Glut microbiota composition

    faecal samples are collected at baseline prior to the study and after each 14 day intervention period

    baseline and after 14 days intervention

  • Working memory capacity

    Working memory capacity determined with an oral working memory test composed of short sentences that can be semantically meaningful or not. 3-5 sentences are read to the subject. After each sentence the subject immediately has to reply if the sentence is semantically meaningful or not. After the set of 3-5 sentences the subjects have to recall the first noun in each of the sentences. One test is composed of 12 set with (3-5) sentences.

    120 min

  • Working memory capacity

    Working memory capacity determined with an oral working memory test composed of short sentences that can be semantically meaningful or not. 3-5 sentences are read to the subject. After each sentence the subject immediately has to reply if the sentence is semantically meaningful or not. After the set of 3-5 sentences the subjects have to recall the first noun in each of the sentences. One test is composed of 12 set with (3-5) sentences.

    160 min

Study Arms (3)

sucrose

EXPERIMENTAL

14 days intervention with daily intake of a beverage (1000 ml) including 66g sucrose.

Other: Sucrose

stevia glycosides

EXPERIMENTAL

14 days intervention with daily intake of a beverage (1000ml) including 0.220 g stevia glycosides.

Other: Stevia glycosides

saccharin

EXPERIMENTAL

14 days intervention with daily intake of a beverage (1000ml) including 0.216g saccharin.

Other: saccharin

Interventions

SucroseOTHER
sucrose
stevia glycosides
saccharin

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy subjects
  • blood glucose \<6.1
  • BMI \<28
  • age between 40-70 years
  • normal diet
  • fluent in Swedish language (due to the structure of the cognitive tests).

You may not qualify if:

  • diabetes
  • cognitive decline (not able to cope with the cognitive tests)
  • metabolic syndrome
  • gastro-intestinal disorders
  • antibiotics or probiotics during the study period
  • smookers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Food for Health Science Centre, Medicon Village, Lund University

Lund, , SE-223 81 LUND, Sweden

Location

MeSH Terms

Interventions

SucroseSaccharin

Intervention Hierarchy (Ancestors)

DisaccharidesOligosaccharidesPolysaccharidesCarbohydratesSugarsThiazolesSulfur CompoundsOrganic ChemicalsBenzothiazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Officials

  • Anne Nilsson, PhD

    Food for Health Science Centre, Lund University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, assocoate professor

Study Record Dates

First Submitted

October 14, 2015

First Posted

October 20, 2015

Study Start

October 1, 2015

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

June 23, 2016

Record last verified: 2016-06

Locations